GT Biopharma, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
44.7M
on 2026-06-30, from 1.38M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3 of 2025-03-06. Not read yet. S-3 ↗
10 of its filings are not read yet.
Cash
1.4 quarters
$5.0M on 2026-06-30 ÷ $3.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-18 | Private placement | not read | not read | $7.8M | 8-K ↗ |
| 2026-09-14 | Private placement | not read | not read | $7.5M | 8-K ↗ |
Also on file: a 1-for-10 reverse split, 2024-07-01 8-K ↗